AU2004285928B2 - Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction - Google Patents
Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction Download PDFInfo
- Publication number
- AU2004285928B2 AU2004285928B2 AU2004285928A AU2004285928A AU2004285928B2 AU 2004285928 B2 AU2004285928 B2 AU 2004285928B2 AU 2004285928 A AU2004285928 A AU 2004285928A AU 2004285928 A AU2004285928 A AU 2004285928A AU 2004285928 B2 AU2004285928 B2 AU 2004285928B2
- Authority
- AU
- Australia
- Prior art keywords
- protein
- target protein
- adsorbent
- flow
- hydrophobic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51448603P | 2003-10-24 | 2003-10-24 | |
US60/514,486 | 2003-10-24 | ||
PCT/US2004/035007 WO2005042569A1 (en) | 2003-10-24 | 2004-10-22 | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2004285928A1 AU2004285928A1 (en) | 2005-05-12 |
AU2004285928B2 true AU2004285928B2 (en) | 2012-02-02 |
Family
ID=34549339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004285928A Active AU2004285928B2 (en) | 2003-10-24 | 2004-10-22 | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
Country Status (8)
Country | Link |
---|---|
US (1) | US7427659B2 (es) |
EP (1) | EP1687328B1 (es) |
AT (1) | ATE462716T1 (es) |
AU (1) | AU2004285928B2 (es) |
CA (1) | CA2542951C (es) |
DE (1) | DE602004026343D1 (es) |
ES (1) | ES2342539T3 (es) |
WO (1) | WO2005042569A1 (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1380290A1 (en) | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-beta structure pathway and its therapeutic relevance |
EP1687328B1 (en) * | 2003-10-24 | 2010-03-31 | Amgen, Inc. | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
MX2007011129A (es) | 2005-03-11 | 2007-11-06 | Wyeth Corp | Un metodo de cromatografia de particion debil. |
US8114832B2 (en) * | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
CA2615028A1 (en) | 2005-07-13 | 2007-01-18 | Crossbeta Biosciences B.V. | Cross-.beta. structure binding compounds |
US20070015133A1 (en) * | 2005-07-13 | 2007-01-18 | Umc Utrecht Holding B.V. | Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein |
US7566401B2 (en) * | 2005-10-03 | 2009-07-28 | Kelm Mark A | Process for separating and isolating xanthines, individual polar protic monomers, and polar protic oligomers |
TWI423986B (zh) | 2005-12-20 | 2014-01-21 | 必治妥美雅史谷比公司 | 組合物及製造組合物之方法 |
AR058568A1 (es) | 2005-12-20 | 2008-02-13 | Bristol Myers Squibb Co | Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo |
CA2711499C (en) | 2008-01-10 | 2018-09-25 | Research Development Foundation | Vaccines and diagnostics for the ehrlichioses |
WO2009126603A1 (en) * | 2008-04-08 | 2009-10-15 | Bio-Rad Laboratories, Inc. | Chromatography purification of antibodies |
CN102099369A (zh) * | 2008-07-18 | 2011-06-15 | 泰勒克里斯生物治疗学公司 | 制备α-1蛋白酶抑制剂的方法 |
EP2445924B2 (en) | 2009-06-25 | 2023-12-13 | Amgen Inc. | Capture purification processes for proteins expressed in a non-mammalian system |
AU2010313395A1 (en) | 2009-10-30 | 2012-05-10 | Abbvie Inc. | sORF constructs and multiple gene expression |
CA2821711C (en) | 2010-12-15 | 2017-10-10 | Baxter International Inc. | Eluate collection using conductivity gradient |
WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
SG10201605397PA (en) | 2011-07-01 | 2016-08-30 | Hoffmann La Roche | Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides |
CA2840951A1 (en) | 2011-07-08 | 2013-01-17 | Merck Sharp & Dohme Corp. | Methods for purifying fc-fusion protein |
KR101454316B1 (ko) | 2011-08-17 | 2014-10-27 | 한화케미칼 주식회사 | 활성형 TNFR-Fc 융합 단백질을 제조하는 방법 |
SG10201701224UA (en) | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
WO2013176754A1 (en) * | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9206390B2 (en) | 2012-09-02 | 2015-12-08 | Abbvie, Inc. | Methods to control protein heterogeneity |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
WO2014143205A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
EP2970378B1 (en) | 2013-03-15 | 2021-05-26 | Biogen MA Inc. | Hydrophobic interaction protein chromatography under no-salt conditions |
EP3052640A2 (en) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
SG10201804200WA (en) | 2013-12-12 | 2018-07-30 | Emd Millipore Corp | Protein separations using an acrylamide containing filter |
KR102405382B1 (ko) * | 2014-03-04 | 2022-06-03 | 메르크 파텐트 게엠베하 | 강건한 항체 정제 |
AR102198A1 (es) | 2014-10-09 | 2017-02-08 | Regeneron Pharma | Proceso para reducir partículas subvisibles en una formulación farmacéutica |
EP3500297A1 (en) | 2016-08-16 | 2019-06-26 | Regeneron Pharmaceuticals, Inc. | Methods for quantitating individual antibodies from a mixture |
PL3532838T3 (pl) | 2016-10-25 | 2022-10-03 | Regeneron Pharmaceuticals, Inc. | Metody i systemy analizy danych chromatograficznych |
EP3668985B1 (en) | 2017-08-17 | 2021-06-16 | Just-Evotec Biologics, Inc. | Method of purifying glycosylated protein from host cell galectins and other contaminants |
TW202005694A (zh) | 2018-07-02 | 2020-02-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
WO2022140389A1 (en) | 2020-12-22 | 2022-06-30 | Amgen Inc. | Cell culture method |
WO2023215750A2 (en) | 2022-05-02 | 2023-11-09 | Regeneron Pharmaceuticals, Inc. | Methods for reducing lipase activity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468847A (en) * | 1994-03-10 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Method of isolating and purifying a biomacromolecule |
WO1996033208A1 (en) * | 1995-04-20 | 1996-10-24 | Genentech, Inc. | Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
US6005082A (en) * | 1994-11-14 | 1999-12-21 | Genetics Institute, Inc. | Process for purification of factor VIII |
WO2000059927A1 (en) * | 1999-04-01 | 2000-10-12 | Cantab Pharmaceuticals Research Limited | Purification of biological preparations |
US20030009025A1 (en) * | 1993-09-21 | 2003-01-09 | Smith Leonard A. | Recombinant vaccine against botulinum neurotoxin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0449299A (ja) * | 1990-06-14 | 1992-02-18 | Tosoh Corp | 免疫グロブリンフラグメントの精製法 |
US5463029A (en) * | 1992-11-23 | 1995-10-31 | Immunex Corporation | Purification of fusion proteins comprising GM-CSF and IL-3 |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
WO2001072769A2 (en) | 2000-03-27 | 2001-10-04 | Genetics Institute, Llc | Methods for purifying highly anionic proteins |
EP1687328B1 (en) * | 2003-10-24 | 2010-03-31 | Amgen, Inc. | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
-
2004
- 2004-10-22 EP EP04796067A patent/EP1687328B1/en active Active
- 2004-10-22 ES ES04796067T patent/ES2342539T3/es active Active
- 2004-10-22 AT AT04796067T patent/ATE462716T1/de not_active IP Right Cessation
- 2004-10-22 WO PCT/US2004/035007 patent/WO2005042569A1/en active Application Filing
- 2004-10-22 CA CA2542951A patent/CA2542951C/en active Active
- 2004-10-22 AU AU2004285928A patent/AU2004285928B2/en active Active
- 2004-10-22 DE DE602004026343T patent/DE602004026343D1/de active Active
- 2004-10-22 US US10/970,860 patent/US7427659B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030009025A1 (en) * | 1993-09-21 | 2003-01-09 | Smith Leonard A. | Recombinant vaccine against botulinum neurotoxin |
US5468847A (en) * | 1994-03-10 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Method of isolating and purifying a biomacromolecule |
US6005082A (en) * | 1994-11-14 | 1999-12-21 | Genetics Institute, Inc. | Process for purification of factor VIII |
WO1996033208A1 (en) * | 1995-04-20 | 1996-10-24 | Genentech, Inc. | Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
WO2000059927A1 (en) * | 1999-04-01 | 2000-10-12 | Cantab Pharmaceuticals Research Limited | Purification of biological preparations |
Non-Patent Citations (2)
Title |
---|
SCHOEL, BERND et al. 'Hydrophobic interaction chromatography for the purification of a mycobacterial heat shock protein of relative molecular mass 60 000.' Journal of Chromatography. 1991, Vol. 587, pages 19-23 * |
SCHOEL, BERND et al. 'Hydrophobic interaction for the purification of cytolytic bacterial toxins.' Journal of Chromatography A. 1994, Vol. 667, pages 131-139 * |
Also Published As
Publication number | Publication date |
---|---|
CA2542951C (en) | 2016-08-30 |
EP1687328B1 (en) | 2010-03-31 |
WO2005042569A1 (en) | 2005-05-12 |
CA2542951A1 (en) | 2005-05-12 |
EP1687328A1 (en) | 2006-08-09 |
AU2004285928A1 (en) | 2005-05-12 |
US7427659B2 (en) | 2008-09-23 |
DE602004026343D1 (de) | 2010-05-12 |
ATE462716T1 (de) | 2010-04-15 |
ES2342539T3 (es) | 2010-07-08 |
US20050136521A1 (en) | 2005-06-23 |
EP1687328A4 (en) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004285928B2 (en) | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction | |
US7122641B2 (en) | Methods for purifying protein | |
WO2007109163A2 (en) | Wash buffer and method of using | |
US11192919B2 (en) | Removal of leaked affinity purification ligand | |
US10023608B1 (en) | Protein purification methods to remove impurities | |
EP2855501B1 (en) | In situ restoration of apatite-based chromatography resins | |
US8273707B2 (en) | Process for purifying proteins | |
WO2006060083A1 (en) | Methods for refolding polypeptides | |
JP2013234154A (ja) | 精製方法 | |
JP2013184919A (ja) | 精製方法 | |
JP2013199454A (ja) | 精製方法 | |
JP2013227254A (ja) | 精製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |